CytoSure™ Syndrome Plus v2 Array
Accurate and reliable detection of DNA aberrations across the genome.
Find out more
For more information about any OGT product or service, please contact us.
Overview
CytoSure™ Syndrome Plus v2 Arrays deliver:
- Extensive genome coverage
- Enhanced detection of chromosomal abnormalities
- High-resolution coverage of clinically relevant regions
- Effortless data interpretation
Ordering Information
| Product | Contents | Cat. No. | Price |
|---|---|---|---|
| CytoSure Syndrome Plus v2 (2x105k) |
Microarray with two arrays of 105,000 spots; CytoSure Interpret Software |
020019 | Get a quote |
Details
Extensive genome coverage
OGT offers a combination of high resolution arrays, labelling kits and analysis software that together provide a unique, comprehensive solution for cytogeneticists.
The CytoSure Syndrome Plus v2 Array, developed in close collaboration with leading cytogeneticists, provides superior coverage of cytogenetic syndromes and accurate whole genome aberration detection. Comprised of 2 x 105,000 oligonucleotide features, this array allows parallel high-resolution detection of DNA aberrations in 2 samples.
The CytoSure Syndrome Plus v2 Array focuses on:
- 85 constitutional syndromes, including Angelman, DiGeorge, Cri du Chat etc.
- Sub-telomere regions to 5Mb
- Recombination hotspots surrounded by segmental duplications
A full list of genetic disorders detected by CytoSure Syndrome Plus v2 Array is available here.
High-resolution coverage of clinically relevant regions
| Feature | Advantage |
| Proprietary probe design | Improved results |
| Extensive genome coverage, including subtelomeres, one probe every 40kb | Even coverage, high- resolution backbone |
| Enhanced probe coverage of >200 syndromes and >400 disease causing genes | Superior coverage of disease-causing genes, better characterisation of sample |
| Fully optimised labelling kit | High signal intensity, better aberration identification |
| Software designed for cytogeneticists | Intuitive software allowing easy interpretation of results |
Enhanced detection of chromosomal abnormalities
Each syndrome-related aberration is targeted by multiple specific probes, allowing accurate detection of copy number variations (CNVs). The probes for this array have been selected from OGT’s proprietary Oligome™ database — a database of over 23 million in silico optimised oligonucleotide probes. CytoSure arrays utilise 60 mer oligonucleotide probes, which have been shown to offer higher signal-to-noise ratios through increased specificity and sensitivity.
Effortless data interpretation
All CytoSure arrays are provided with our complimentary, industry-leading CytoSure Interpret Software — a powerful, easy-to-use package for the analysis of aCGH data (Figure 1). Innovative features such as the Accelerate Workflow enable standardised and automated data analysis. In addition, extensive annotation tracks covering syndromes, genes, exons, CNV and recombination hotspots — each of which link to publicly available databases — provide results in context.

Figure 1. CytoSure Syndrome Plus v2 Array data showing deletions on a) chromosome 9 and b) chromosome 15.
Order Information
| Product | Contents | Cat. No. | Price |
|---|---|---|---|
| CytoSure Syndrome Plus v2 (2x105k) |
Microarray with two arrays of 105,000 spots; CytoSure Interpret Software |
020019 | Get a quote |
Related products
| CytoSure Genomic DNA Labelling Kit | 24 reactions: clean-up columns, dyes, nucleotide mix, random primers, enzyme, collection tubes | 020022 | Get a quote |
CytoSure™ products are for research use only.
Resources
FAQs
Article
-
Better by design — a key CytoSure advantage
-
DNA Storage and Quality
-
Gene genie: The laboratory informatics used in genomics
This article, which appeared in the latest issue of Scientific Computing World, addresses the data interpretation challenges presented by high resolution genome analysis techniques such as microarray and sequencing. Exclusive access to OGT Cytogenetics Ne
-
Identifying ozone damage on your arrays
-
Pooling expertise in genetic testing: an innovative approach to NHS cytogenetics
Published in Pathology in Practice, this article addresses how healthcare providers can benefit from faster, more accurate and cost-effective array-based diagnosis of constitutional disorders.
-
Selecting the right CytoSure array format for your study
-
Understanding and measuring variations in DNA sample quality
-
Understanding array quality control (QC) metrics for CytoSure arrays